Reports

Industry Research Reports

Global Virus-like Particles (VLPs) Delivery System Market Insights, Forecast to 2030

Global Virus-like Particles (VLPs) Delivery System Market Insights, Forecast to 2030

Industry: Service & Software

Published Date: 2024-11-12

Pages: 129 Pages

Report ld: 3374200

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose their original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.

The US & Canada market for Virus-like Particles (VLPs) Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The China market for Virus-like Particles (VLPs) Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for Virus-like Particles (VLPs) Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key manufacturers of Virus-like Particles (VLPs) Delivery System include WuXi Biologics, Creative Biolabs, Creative Biogene, Creative Biostructure, Cusabio Technology LLC, Creative Diagnostics, ARTES Biotechnology GmbH, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Virus-like Particles (VLPs) Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Virus-like Particles (VLPs) Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Virus-like Particles (VLPs) Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Virus-like Particles (VLPs) Delivery System revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Virus-like Particles (VLPs) Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Virus-like Particles (VLPs) Delivery System revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including WuXi Biologics, Creative Biolabs, Creative Biogene, Creative Biostructure, Cusabio Technology LLC, Creative Diagnostics, ARTES Biotechnology GmbH, etc.

MARKET SEGMENTATION

By Company

  • WuXi Biologics
  • Creative Biolabs
  • Creative Biogene
  • Creative Biostructure
  • Cusabio Technology LLC
  • Creative Diagnostics
  • ARTES Biotechnology GmbH

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Insect Cell System
  • Mammalian Cell System
  • Plant System
  • Yeast System
  • E. coli System

Segment by Application

  • DNA
  • RNA
  • Peptide
  • Protein
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Revenue of Virus-like Particles (VLPs) Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 3: Detailed analysis of Virus-like Particles (VLPs) Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

marn_i1

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

marn_i1

Chapter 8: China by Type, and by Application, revenue for each segment.

marn_i1

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

marn_i1

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

marn_i1

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Virus-like Particles (VLPs) Delivery System revenue, gross margin, and recent development, etc.

marn_i1

Chapter 12: Analyst's Viewpoints/Conclusions

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Virus-like Particles (VLPs) Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Insect Cell System

1.2.3 Mammalian Cell System

1.2.4 Plant System

1.2.5 Yeast System

1.2.6 E. coli System

1.3 Market by Application

1.3.1 Global Virus-like Particles (VLPs) Delivery System Market Share by Application: 2019 VS 2023 VS 2030

1.3.2 DNA

1.3.3 RNA

1.3.4 Peptide

1.3.5 Protein

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Virus-like Particles (VLPs) Delivery System Market Perspective (2019-2030)

2.2 Global Virus-like Particles (VLPs) Delivery System Growth Trends by Region

2.2.1 Global Virus-like Particles (VLPs) Delivery System Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Virus-like Particles (VLPs) Delivery System Historic Market Size by Region (2019-2024)

2.2.3 Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Region (2025-2030)

2.3 Virus-like Particles (VLPs) Delivery System Market Dynamics

2.3.1 Virus-like Particles (VLPs) Delivery System Industry Trends

2.3.2 Virus-like Particles (VLPs) Delivery System Market Drivers

2.3.3 Virus-like Particles (VLPs) Delivery System Market Challenges

2.3.4 Virus-like Particles (VLPs) Delivery System Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Revenue Virus-like Particles (VLPs) Delivery System by Players

3.1.1 Global Virus-like Particles (VLPs) Delivery System Revenue by Players (2019-2024)

3.1.2 Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Players (2019-2024)

3.2 Global Virus-like Particles (VLPs) Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Virus-like Particles (VLPs) Delivery System, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Virus-like Particles (VLPs) Delivery System Market Concentration Ratio

3.4.1 Global Virus-like Particles (VLPs) Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Virus-like Particles (VLPs) Delivery System Revenue in 2023

3.5 Global Key Players of Virus-like Particles (VLPs) Delivery System Head office and Area Served

3.6 Global Key Players of Virus-like Particles (VLPs) Delivery System, Product and Application

3.7 Global Key Players of Virus-like Particles (VLPs) Delivery System, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

muLu

4 Virus-like Particles (VLPs) Delivery System Breakdown Data by Type

4.1 Global Virus-like Particles (VLPs) Delivery System Historic Market Size by Type (2019-2024)

4.2 Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Type (2025-2030)

muLu

5 Virus-like Particles (VLPs) Delivery System Breakdown Data by Application

5.1 Global Virus-like Particles (VLPs) Delivery System Historic Market Size by Application (2019-2024)

5.2 Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Application (2025-2030)

muLu

6 North America

6.1 North America Virus-like Particles (VLPs) Delivery System Market Size (2019-2030)

6.2 North America Virus-like Particles (VLPs) Delivery System Market Size by Type

6.2.1 North America Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)

6.2.2 North America Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)

6.2.3 North America Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)

6.3 North America Virus-like Particles (VLPs) Delivery System Market Size by Application

6.3.1 North America Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)

6.3.2 North America Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)

6.3.3 North America Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)

6.4 North America Virus-like Particles (VLPs) Delivery System Market Size by Country

6.4.1 North America Virus-like Particles (VLPs) Delivery System Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024)

6.4.3 North America Virus-like Particles (VLPs) Delivery System Market Share by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

muLu

7 Europe

7.1 Europe Virus-like Particles (VLPs) Delivery System Market Size (2019-2030)

7.2 Europe Virus-like Particles (VLPs) Delivery System Market Size by Type

7.2.1 Europe Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)

7.2.2 Europe Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)

7.2.3 Europe Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)

7.3 Europe Virus-like Particles (VLPs) Delivery System Market Size by Application

7.3.1 Europe Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)

7.3.2 Europe Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)

7.3.3 Europe Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)

7.4 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country

7.4.1 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024)

7.4.3 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2025-2030)

7.4.4 Germany

7.4.5 France

7.4.6 U.K.

7.4.7 Italy

7.4.8 Russia

7.4.9 Nordic Countries

muLu

8 China

8.1 China Virus-like Particles (VLPs) Delivery System Market Size (2019-2030)

8.2 China Virus-like Particles (VLPs) Delivery System Market Size by Type

8.2.1 China Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)

8.2.2 China Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)

8.2.3 China Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)

8.3 China Virus-like Particles (VLPs) Delivery System Market Size by Application

8.3.1 China Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)

8.3.2 China Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)

8.3.3 China Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)

muLu

9 Asia (excluding China)

9.1 Asia Virus-like Particles (VLPs) Delivery System Market Size (2019-2030)

9.2 Asia Virus-like Particles (VLPs) Delivery System Market Size by Type

9.2.1 Asia Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)

9.2.2 Asia Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)

9.2.3 Asia Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)

9.3 Asia Virus-like Particles (VLPs) Delivery System Market Size by Application

9.3.1 Asia Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)

9.3.2 Asia Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)

9.3.3 Asia Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)

9.4 Asia Virus-like Particles (VLPs) Delivery System Market Size by Region

9.4.1 Asia Virus-like Particles (VLPs) Delivery System Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Virus-like Particles (VLPs) Delivery System Market Size by Region (2019-2024)

9.4.3 Asia Virus-like Particles (VLPs) Delivery System Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

muLu

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Type

10.2.1 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Application

10.3.1 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country

10.4.1 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

muLu

11 Key Players Profiles

11.1 WuXi Biologics

11.1.1 WuXi Biologics Company Details

11.1.2 WuXi Biologics Business Overview

11.1.3 WuXi Biologics Virus-like Particles (VLPs) Delivery System Introduction

11.1.4 WuXi Biologics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.1.5 WuXi Biologics Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Virus-like Particles (VLPs) Delivery System Introduction

11.2.4 Creative Biolabs Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.2.5 Creative Biolabs Recent Development

11.3 Creative Biogene

11.3.1 Creative Biogene Company Details

11.3.2 Creative Biogene Business Overview

11.3.3 Creative Biogene Virus-like Particles (VLPs) Delivery System Introduction

11.3.4 Creative Biogene Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.3.5 Creative Biogene Recent Development

11.4 Creative Biostructure

11.4.1 Creative Biostructure Company Details

11.4.2 Creative Biostructure Business Overview

11.4.3 Creative Biostructure Virus-like Particles (VLPs) Delivery System Introduction

11.4.4 Creative Biostructure Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.4.5 Creative Biostructure Recent Development

11.5 Cusabio Technology LLC

11.5.1 Cusabio Technology LLC Company Details

11.5.2 Cusabio Technology LLC Business Overview

11.5.3 Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Introduction

11.5.4 Cusabio Technology LLC Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.5.5 Cusabio Technology LLC Recent Development

11.6 Creative Diagnostics

11.6.1 Creative Diagnostics Company Details

11.6.2 Creative Diagnostics Business Overview

11.6.3 Creative Diagnostics Virus-like Particles (VLPs) Delivery System Introduction

11.6.4 Creative Diagnostics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.6.5 Creative Diagnostics Recent Development

11.7 ARTES Biotechnology GmbH

11.7.1 ARTES Biotechnology GmbH Company Details

11.7.2 ARTES Biotechnology GmbH Business Overview

11.7.3 ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Introduction

11.7.4 ARTES Biotechnology GmbH Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)

11.7.5 ARTES Biotechnology GmbH Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Virus-like Particles (VLPs) Delivery System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Insect Cell System
Table 3. Key Players of Mammalian Cell System
Table 4. Key Players of Plant System
Table 5. Key Players of Yeast System
Table 6. Key Players of E. coli System
Table 7. Global Virus-like Particles (VLPs) Delivery System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Virus-like Particles (VLPs) Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Virus-like Particles (VLPs) Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Virus-like Particles (VLPs) Delivery System Market Share by Region (2019-2024)
Table 11. Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Virus-like Particles (VLPs) Delivery System Market Share by Region (2025-2030)
Table 13. Virus-like Particles (VLPs) Delivery System Market Trends
Table 14. Virus-like Particles (VLPs) Delivery System Market Drivers
Table 15. Virus-like Particles (VLPs) Delivery System Market Challenges
Table 16. Virus-like Particles (VLPs) Delivery System Market Restraints
Table 17. Global Virus-like Particles (VLPs) Delivery System Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Virus-like Particles (VLPs) Delivery System Market Share by Players (2019-2024)
Table 19. Global Top Virus-like Particles (VLPs) Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particles (VLPs) Delivery System as of 2023)
Table 20. Global Virus-like Particles (VLPs) Delivery System Industry Ranking 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Virus-like Particles (VLPs) Delivery System Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Virus-like Particles (VLPs) Delivery System, Headquarters and Area Served
Table 23. Global Key Players of Virus-like Particles (VLPs) Delivery System, Product and Application
Table 24. Global Key Players of Virus-like Particles (VLPs) Delivery System, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Type (2019-2024)
Table 28. Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Type (2025-2030)
Table 30. Global Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Application (2019-2024)
Table 32. Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Application (2025-2030)
Table 34. North America Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Virus-like Particles (VLPs) Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Virus-like Particles (VLPs) Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Virus-like Particles (VLPs) Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Virus-like Particles (VLPs) Delivery System Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Virus-like Particles (VLPs) Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Virus-like Particles (VLPs) Delivery System Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 66. WuXi Biologics Company Details
Table 67. WuXi Biologics Business Overview
Table 68. WuXi Biologics Virus-like Particles (VLPs) Delivery System Product
Table 69. WuXi Biologics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 70. WuXi Biologics Recent Development
Table 71. Creative Biolabs Company Details
Table 72. Creative Biolabs Business Overview
Table 73. Creative Biolabs Virus-like Particles (VLPs) Delivery System Product
Table 74. Creative Biolabs Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 75. Creative Biolabs Recent Development
Table 76. Creative Biogene Company Details
Table 77. Creative Biogene Business Overview
Table 78. Creative Biogene Virus-like Particles (VLPs) Delivery System Product
Table 79. Creative Biogene Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 80. Creative Biogene Recent Development
Table 81. Creative Biostructure Company Details
Table 82. Creative Biostructure Business Overview
Table 83. Creative Biostructure Virus-like Particles (VLPs) Delivery System Product
Table 84. Creative Biostructure Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 85. Creative Biostructure Recent Development
Table 86. Cusabio Technology LLC Company Details
Table 87. Cusabio Technology LLC Business Overview
Table 88. Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Product
Table 89. Cusabio Technology LLC Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 90. Cusabio Technology LLC Recent Development
Table 91. Creative Diagnostics Company Details
Table 92. Creative Diagnostics Business Overview
Table 93. Creative Diagnostics Virus-like Particles (VLPs) Delivery System Product
Table 94. Creative Diagnostics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 95. Creative Diagnostics Recent Development
Table 96. ARTES Biotechnology GmbH Company Details
Table 97. ARTES Biotechnology GmbH Business Overview
Table 98. ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Product
Table 99. ARTES Biotechnology GmbH Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024) & (US$ Million)
Table 100. ARTES Biotechnology GmbH Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Global Virus-like Particles (VLPs) Delivery System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Virus-like Particles (VLPs) Delivery System Market Share by Type: 2023 VS 2030
Figure 3. Insect Cell System Features
Figure 4. Mammalian Cell System Features
Figure 5. Plant System Features
Figure 6. Yeast System Features
Figure 7. E. coli System Features
Figure 8. Global Virus-like Particles (VLPs) Delivery System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Virus-like Particles (VLPs) Delivery System Market Share by Application: 2023 VS 2030
Figure 10. DNA Case Studies
Figure 11. RNA Case Studies
Figure 12. Peptide Case Studies
Figure 13. Protein Case Studies
Figure 14. Other Case Studies
Figure 15. Virus-like Particles (VLPs) Delivery System Report Years Considered
Figure 16. Global Virus-like Particles (VLPs) Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Virus-like Particles (VLPs) Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Virus-like Particles (VLPs) Delivery System Market Share by Region: 2023 VS 2030
Figure 19. Global Virus-like Particles (VLPs) Delivery System Market Share by Players in 2023
Figure 20. Global Top Virus-like Particles (VLPs) Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particles (VLPs) Delivery System as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Virus-like Particles (VLPs) Delivery System Revenue in 2023
Figure 22. North America Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
Figure 24. North America Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
Figure 25. North America Virus-like Particles (VLPs) Delivery System Market Share by Country (2019-2030)
Figure 26. United States Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
Figure 30. Europe Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
Figure 31. Europe Virus-like Particles (VLPs) Delivery System Market Share by Country (2019-2030)
Figure 32. Germany Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
Figure 40. China Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
Figure 41. Asia Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Asia Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
Figure 43. Asia Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
Figure 44. Asia Virus-like Particles (VLPs) Delivery System Market Share by Region (2019-2030)
Figure 45. Japan Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Virus-like Particles (VLPs) Delivery System Market Share by Country (2019-2030)
Figure 55. Brazil Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Virus-like Particles (VLPs) Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. WuXi Biologics Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 62. Creative Biolabs Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 63. Creative Biogene Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 64. Creative Biostructure Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 65. Cusabio Technology LLC Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 66. Creative Diagnostics Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 67. ARTES Biotechnology GmbH Revenue Growth Rate in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Virus-like Particles (VLPs) Delivery System market?zhanKai
The top companies in the global Virus-like Particles (VLPs) Delivery System market are WuXi Biologics、Creative Biolabs、Creative Biogene.
den_biaoTiZhungShi

Related Reports

Global Virus-like Particles (VLPs) Delivery System Market Insights, Forecast to 2030

Industry: Service & Software

Published Date: 2024-11-12

Pages: 129 Pages

Report ld: 3374200

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now